Corey Williams
Corey Williams's Latest Posts
BST Trade Alert: January 23, 2013
January 23, 2013 Recommendation: Buy MannKind (NASDAQ: MNKD) up to $2.85 per share. About the Company: MannKind is a clinical stage biotech on the brink of a major breakthrough. Phase 3 testing of their potential blockbuster product for diabetes is almost complete. And FDA approval could come as early as the first half of 2014. With such […]
BST Position Update: January 18, 2013
January 18, 2013 . . . . Array BioPharma (NASDAQ: ARRY) – Buy up to $4.80 We’re very excited about our latest addition to the portfolio, Array BioPharma. This small biotech is developing a number of drugs to treat cancer and inflammatory diseases. Why are we so excited? ARRY has a robust pipeline of 14 […]
SET Monthly Issue January 2013
January 2013 A RIVER OF CASH! Happy New Year! Investors aren’t wasting any time this year. A river of cash the size of the Amazon is flowing into stocks. According to fund watcher Lipper, investors poured a whopping $18.3 billion into stock funds during the first full week of trading in 2013. It was the […]
BST Trade Alert: January 10, 2013
January 10, 2013 Recommendation: Buy Array BioPharma (NASDAQ: ARRY) up to $4.80 per share. About the Company: Advancing a new drug through clinical testing to FDA approval is a long and costly process. As a result, most small biotechs focus their limited resources on developing just one or two new drugs. And the vast majority of their […]
BST Position Update: January 4, 2013
January 4, 2013 . . . . Trius Therapeutics (NASDAQ: TSRX) – Hold In our last update, we urged you to view the pullback in TSRX as a buying opportunity. We believed then, as we do now, that investors would push the stock higher ahead of the upcoming phase 3 trial results for tedizolid phosphate. […]
SET Portfolio Update January 2013
January 2, 2013 Dear Sector ETF Trader Reader, Happy New Year! And it is a happy one after Congress approved a fiscal cliff compromise late Tuesday night. Investors everywhere are breathing a sigh of relief today. The plan extends the Bush era tax cuts for individuals making less than $400,000 per year and couples earning […]
EOT Trade Alert – December 31, 2012
December 31, 2012 Trade Alert: Buy MCD Feb 2013 $85 Puts at $1.30 or better Company Background: McDonald’s (MCD) doesn’t need an introduction. The iconic American fast food restaurant operates 34,000 locations in 120 countries around the world. Short-Term Catalyst: Don’t get me wrong, I love McDonald’s as much as the next guy. But the short […]
EOT Position Update – December 26, 2012
December 26, 2012 Market Snapshot Merry Christmas and Happy Holidays! The markets are re-opening with holiday hangover after being closed for Christmas yesterday. The S&P 500 has shed 0.5% today on light volume. Shares of retailers are getting hammered today. It appears that the amount of money holiday shoppers spent this year increased 0.7%. That’s […]
EOT Position Update – December 19, 2012
December 19, 2012 Market Snapshot Another week with more of the same… You guessed it. Investors are focused on the fiscal cliff. As the negotiations between President Obama and House Speaker Boehner go back and forth, the markets seem to ebb and flow with every comment. Judging by the S&P 500’s strong performance this week, […]
SET Monthly Issue December 2012
December 2012 BUILDING A BETTER FUTURE! Merry Christmas and Happy Holidays… Welcome to the final issue of Sector ETF Traderfor 2012. One thing’s for sure, 2012 didn’t have a shortage of catalysts to drive market action. It’s been an exciting year full of twists and turns. Some catalysts we’re positive… For instance, the housing market […]
